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Abstract
Background: In Malaysia, the number of reported cases of dengue fever demonstrates an increasing trend. Since
dengue fever has no vaccine or antiviral treatment available, it has become a burden. Complementary and
alternative medicine (CAM) has become one of the good alternatives to treat the patients with dengue fever. There
is limited study on the use of CAM among patients with dengue fever, particularly in hospital settings. This study
aims to determine the prevalence, types, reasons, expenditure, and resource of information on CAM use among
patients with dengue fever.
Methods: This is a descriptive, cross-sectional study of 306 patients with dengue fever, which was carried out at the
dengue clinic of three hospitals. Data were analysed using IBM SPSS Statistics version 21.0 and logistic regression analysis
was used to determine the factors associated with CAM use.
Results: The prevalence of CAM use was 85.3 % among patients with dengue fever. The most popular CAMs were
isotonic drinks (85.8 %), crab soup (46.7 %) and papaya leaf extract (22.2 %). The most common reason for CAM use
was a good impression of CAM from other CAM users (33.3 %). The main resource of information on CAM use among
patients with dengue fever was family (54.8 %). In multiple logistic regression analysis, dengue fever patients with a
tertiary level are more likely to use CAM 5.8 (95 % confidence interval (CI 1.62–20.45) and 3.8 (95 % CI 1.12–12.93) times
than secondary level and primary and below respectively.
Conclusion: CAM was commonly used by patients with dengue fever. The predictor of CAM use was a higher level of
education.
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Background
Complementary and alternative medicine (CAM) is a
group of various medical and healthcare systems, prod-
ucts, practices, approaches, knowledge and beliefs, which
are not universally considered as a part of conventional
Western medicine for maintaining well-being [1, 2]. The
National Center for Complementary and Integrative
Health classified CAM into five subdivisions: biological-
based therapies, alternative medical systems, energy
therapies, manipulative and body-based systems, and
mind-body interventions [1, 3].
A patient who desires to maintain and improve their
physical, psychological and social well-being will tend to
use CAM [4]. With the rising trend of dengue fever
(DF) cases from 1999 to 2007 [5] and high incidence
rates of dengue in Malaysia in 2011 [6], more patients
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will look up to CAM as an alternative form of treatment.
Furthermore, a fool proof antiviral treatment for DF cur-
rently does not exist [7] and the development of safe
tetravalent dengue vaccine is still undergoing clinical tri-
als [8–10]. Therefore, the treatment is only supportive
and symptomatic in nature. In addition, DF also carries
the risk of developing into dengue haemorrhagic fever
where the mortality rate is up to 44 % [11]. Living with
these circumstances, patients began to realise that they
need to take action to manage their condition by taking
CAM [4].
For decades, several studies have shown the positive
effect of CAM for DF treatment. Especially the fresh pa-
paya leaf extracts [12, 13], bitter melon (Momordica
charantia), green chirayta (Andrographis paniculata)
[14], boneset (Eupatorium perfoliatum) [15]. Double-
boiled frog with bitter gourd soup and the whole crab
soup are the famous dishes used as CAM for treating
DF among Chinese ethnics in Malaysia [16].
Although the scientists and the various governments
are developing the effective prevention and control mea-
sures, including antiviral drugs and vaccines, CAM
could provide good antiviral results as compared to their
synthetic analogues [17, 18]. There is a necessity to re-
think over medical education, increase the understand-
ing of the concept of medicine and integrating CAM
therapies in mainstream health care services [19]. How-
ever, the usage of CAM for DF treatment through safe
and effective technologies are strongly recommended.
Thus, this study aims to determine the prevalence, types,




This is a cross-sectional study of patient with DF attend-
ing the dengue clinic at Hospital Serdang, Hospital
Kajang and Hospital Kuala Lumpur, Selangor, Malaysia.
The sample was collected one off.
Inclusion criteria
All patients above 18 years of age presented with a
history of fever and evidence of thrombocytopenia
(platelet count <150 × 109/L) with or without dengue
seropositivity were eligible for the study. To the best
of our knowledge, there was no previous study on the
prevalence of CAM use among patients with dengue.
The sample size was calculated using Epi Info 7.0.
The pilot study were conducted among 30 patients
using the questionnaire to test for the patient’s under-
standing and to anticipate any potential problem par-
ticularly in term of response rate, from there we also
managed to calculate the sample size. The sample
were excluded from the analysis later on.
Based on the results of our pilot study, the prevalence
of CAM use was 53.3 %. The estimated sample size was
269 with 90 % power, 95 % confidence interval (CI) and
statistical significance level (α) at 5 %. The total number
of respondents required was 309 after considering a
non-response rate of 15 %. Universal sampling method
was used to recruit the patients in the dengue clinic at
Hospital Serdang, Hospital Kajang, and Hospital Kuala
Lumpur.
Data collection
A face-to-face interview was conducted by using a ques-
tionnaire. A written consent form was obtained from the
respondents. The questionnaire was designed to capture
the information on patients’ socio-demographic data, co-
morbidity, types of CAM use, reasons for CAM use, re-
sources consulted and the amount of expenditure on
CAM (Refer to Additional file 1 on questionnaire). The
survey was carried out during the first 3 weeks of July
2014.
Practical definition
A dengue patient was defined as someone who had the
history of fever and clinically diagnosed with
thrombocytopenia with platelet count <150 × 109/L with
or without dengue seropositivity. Dengue seropositivity
was not used as a must criteria to diagnose dengue in
this study because the serologically test only confirmed
cases of dengue by approximately 40–50 % at the time
of notification and fever accounts for almost 95 % of all
reported cases [5].
In this study, CAM use was defined as the consump-
tion of at least one out of the five types of CAM therap-
ies; biological-based therapies (herbal and dietary
supplements), alternative medical systems (including
acupuncture, Ayurvedic and homeopathy), energy ther-
apies (such as Qi Gong or Reiki), manipulative and
body-based therapies (such as chiropractic care and
massage) and mind (body intervention therapies (such
as shamanism and yoga) [1, 3].
Data analysis
Statistical analysis was conducted by using the IBM
statistical package for the social sciences (SPSS) ver-
sion 21.0. Categorical data were reported as propor-
tions (percentage). Chi-square test or Fisher exact
test was used for the categorical or dichotomous
variables. Multiple logistic regression analysis was
used to look for predictors of CAM use among pa-
tient with DF. All variables with the p value less
than 0.25 in the simple logistic regression as well as
clinically significant variables were entered into the
multiple logistic regression. The dependent variable
was CAM use. The independent variables were age,
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education level, duration of DF and household in-
come. After adjustments were made for possible
confounding factors (model 1: religion, ethnicity,
education level and total family income) model 2: re-
ligion, ethnicity, education level, total family income
and duration of dengue fever), multiple logistic re-
gression were performed. We hypothesized that pa-
tient with low education level are tend to use CAM
compared to those with higher education level. All
analyses were made with 95 % CI, and the level of
significance was set at p < 0.05.
Ethical approval
Ethical approval was obtained from the Ethics Commit-
tee of National Malaysia Research Registry (NMRR-14-
420-20622).
Results
A total of 326 patient with DF were eligible for this
study. Out of these, 20 patients refused to participate
in the study. In the end, 306 patients with DF were
enrolled into the study with the response rate of
93.9 %. Table 1 compares the characteristics of those
with and without CAM use. Overall, the median age
of the patients was 28 years with 58.4 % men. Most
of them came from the white collar category with a
background of secondary education (51.6 %) and
monthly family income of RM 3000 (USD 803). Most
of the respondents were categorized into classic DF
(98.7 %) and a minority of them had dengue
hemorrhagic fever (1.3 %). The mean duration of DF
was 6 days. During univariate analysis, we found that
the level of education (p = 0.01), monthly family
Table 1 Comparison in clinical variables between suspected dengue patient with or without CAM use (N = 306)
Socio-demographic factors CAM Users n = 261, (%) Non-CAM Users n = 45, (%) p-value
Male 156 (86.7) 24 (13.3) 0.42
Female 105 (83.3) 21 (16.7)
Ethnicity
Malay 209 (86.7) 32 (13.3) 0.17
Non Malay 50 (80.0) 13 (20.0)
Religion
Muslim 210 (86.8) 32 (13.2) 0.15
Non-Muslims 51 (79.7) (64.7) 13 (0.3) (35.3)
Level of Education
Primary 7 (58.3) 5 (41.7) 0.01*
Secondary 133 (84.2) 25 (15.8)
Tertiary 121 (89.0) 15 (11.0)
Occupation
No Occupation 75 (77.6) 16 (17.6) 0.37
Blue Collar 67 (85.9) 11 (14.1)
Non-blue Collar 119 (86.9) 18 (13.1)
Age (years)
18–27 119 (85.0) 21 (15.0) 0.87
28–37 85 (86.7) 13 (13.3)
> 38 57 (83.8) 11 (16.2)
Monthly Family Income (RM)
0–2500 113 (81.3) 26 (18.7) 0.13
2501–5000 109 (87.2) 16 (12.8)
> 5001 39 (92.9) 3 (12.0)
Duration of dengue fever (days)
1–3 18 (72.0) 7 (28.0) 0.13
4–6 161 (85.6) 27 (14.4)
> 7 82 (88.2) 11 (11.8)
*There is significant association if p-value < 0.05
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income (p = 0.03) and the duration of DF had an as-
sociation with CAM use (p = 0.02).
Types of CAM used by patient with DF
Total CAM use of the patient with DF was 85.3 % (N =
261) with 95 % CI 0.81–0.89. Table 2 shows the type of
CAM used by patients with DF. Biological therapies that
involved dietary supplements (98.1 %) and herbal products
(22.2 %) were the most commonly used. The most popular
type of CAM was isotonic drink (85.8 %), followed by crab
soup (46.7 %), papaya leaf extract (22.2 %), coconut juice
(20.3 %) and watermelon (17.2 %).
Attitudes, beliefs and perceptions towards CAM
The mean duration of CAM use was 4 days. Table 3
shows the reasons, resources and expenditure of
using CAM among patient with DF. One-third of
the patients consumed CAM because they had a
good impression from other CAM users. Another
one-third of them just wanted to try it (32.2 %).
About one-fifth (22.6 %) of them took it under the
influence of family members. Most of the patients
received information on CAM from their families
(54.8 %), followed by friends (31 %), doctors (9.6 %),
neighbors (2.3 %) and media (2.3 %). During DF, the
median expenditure on CAM was RM 16.50 (USD
4.42) and more than half (57.1 %) of the patients
spent less than RM 20.00 on CAM.
Multiple logistic regression
Table 4 shows the results of multiple logistic regressions.
In multiple logistic regression analysis, after adjusting
for all the variables in the model, education was the
main predictor. Dengue fever patients with a tertiary
level are more likely to use CAM 5.8 (95 % confidence
interval (CI 1.62–20.45) and 3.8 (95 % CI 1.12–12.93)
times than secondary level and primary and below
respectively.
Discussion
Dengue is a severe threat in various countries and there
is still no specific treatment. Researchers are keen to
identify a potential antiviral drug, generic compounds
and natural products against dengue infection [7, 18].
On the other hand, people have started using CAM such
as the extracts of Carica papaya and other dietary com-
plements, as they believe that CAM is more effective
against dengue. Taking this into account, this study had
been conducted on 261 CAM users and 45 non-CAM
users among patient with DF. The prevalence of CAM
use (85.3 %) among dengue patients was high in com-
parison with non-CAM user. This finding was consistent
with the studies on CAM use against chronic diseases
such as diabetes mellitus [20, 21] and hypertension [22].
Table 2 Type of CAM used by patients with dengue fever (N =
261)




Biological-based therapies 261 100.0
Herbal Supplement 58 22.2
Papaya leaf extract 58 22.2
Dietary Supplement 256 98.1
Isotonic drink 224 85.8
Crab soup 122 46.7
Coconut Juice 53 20.3
Watermelon 45 17.2
Chicken soup 25 9.6
Vitamin Supplement 21 8.0
Guava Juice 11 4.2
Boiled frog meat with bitter
gourd
8 3.1
Other Juices 26 10.1
Alternative medical system 1 0.4




Mind-body intervention 12 4.6
Table 3 Reasons for CAM use, source of information and






Reason for using CAM
• Have good impression on CAM from
other CAM users
87 33.3
• Just want to try 84 32.2
• Due to family belief and tradition 59 22.6
• Lesser side effects than conventional
medicines
9 3.4
• Dissatisfied with conventional medicines 0 0
• Others 22 8.4
CAM Information Source
• Family 143 54.8
• Friends 81 31
• Doctor 25 9.6
• Neighbour 6 2.3
• Media 6 2.3
Amount of expenditure (RM)
• RM0.00-19.99 149 57.1
• RM20.00-39.99 65 24.9
• RM40.00-59.99 34 13
• > RM60.00 13 5
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It was also supported by another study on CAM use
against acute diseases like asthma [23].
A study was conducted on the use of Carica papaya
leaf juice in dengue patients and the results showed a
significant increase in the platelet count of these patients
[13]. Surprisingly, beverage like isotonic drinks (85.8 %)
and food like crab soup (46.7 %) become the commonest
CAM use in our study. Some of the patients claiming
that having isotonic drink was useful, however, it shows
no proof in reducing DF [24]. Despite it did not have
any therapeutic effect in curing DF but it gives a sup-
portive effect that helps the dengue patient to regain en-
ergy [25]. Also, people from various demographics
believed that isotonic drink drinks were able to treat DF,
although they did not know the mechanism of action
[16]. However, this isotonic drink might also endanger
the life of a diabetic patient if they over consume it dur-
ing DF [24, 26].
Although many studies found that papaya leaf have a
significant effect on DF [12, 13], only one fifth (22.2 %) of
dengue patients in this study consumed it. It seems pos-
sible that this result is due to the bitter taste of the papaya
leaf [27–29] which make it less favorable choice as patient
with DF also suffered from poor appetite [30–33].
In this study, we found that one-third of the patient
with DF used CAM because they had a good impression
of CAM from other CAM users. This has usually been
under the influence of other patients in the same hos-
pital and they believed that CAM can relieve their symp-
toms and help them recover faster from DF. Another
one-third of them just wanted to try it (32.2 %) and this
was consistent with another local study on the reasons
of CAM use in patients with chronic diseases [22]. This
belief differed from another previous local study where
the main reason for CAM use among patients with dia-
betes was the quality and safety of CAM [34]. In
addition, we found that none of the CAM users were
dissatisfied with the conventional medicines. This find-
ing was consistent with another local study [20].
The main source of information on CAM use
among patient with DF was family (54.8 %). These re-
sults differed from some published studies on CAM
where most of the respondents obtained information
on CAM principally from their friends [19]. During
DF, the median expenditure on CAM was RM 16.50
(USD4.42) and more than half (57.1 %) of the pa-
tients spent less than RM 20.00 on CAM. This find-
ing was in agreement with the local studies that
showed that the expenditure on CAM was generally
low [20, 22]. This finding further supported the previ-
ous published study where patients who tried to use
CAM had lower monthly expenditures compared to
those who did not use CAM [35].
In our study, those who obtained a tertiary level of
education (89 %) were more likely to use CAM com-
pared to others. This was due to their environment
where educated people were more aware about the com-
plications of low platelet count, which in turn caused
them to look for a supplement including CAM. This re-
sult was consistent with another study, which demon-
strated that individuals with higher educational levels
had a better knowledge and perception towards certain
diseases and this lead them to be more self-empowered
in terms of their own health [32, 33].
Strengths and limitations
The study would have been better if simple random sam-
pling was used instead of universal sampling for all the re-
spondents attended to dengue clinic. Ideally, data should
be collected repeatedly during the illness and when the
patients are fully recovered from DF to determine all the
types of CAM use during the duration of a patient’s ill-
ness. However, it was done because of the lack of man-
power and time constraint. Besides that the findings on
association both univariate and multiple logistic regression
have to be interpreted with cautious due to small number
of sample. Thus future population based study with a big-
ger sample size is recommended to be carried out.
Conclusion
The study demonstrated the CAM use among patients DF
was high. A higher level of education was known to be the
factor associated with CAM use. The most common
CAM used among DF were isotonic drinks, crab soup and
Table 4 Predictors of CAM use among patients with dengue
fever (N = 306)
Variables OR 95 % C.I. Sig.
Lower Upper
Education level 0.02
Tertiary level 5.76 1.62 20.45 0.01
Secondary level 3.80 1.12 12.93 0.03
Primary and below 1.00
Religion Muslim 1.16 0.05 24.75 0.92
Non-Muslims 1.00
Category income 0.42
> RM5000 2.30 0.62 8.45 0.21
RM2501–RM5000 1.30 0.64 2.64 0.47
RM0–RM2500 1.00 0.33
Ethnicity Malay 1.62 0.78 3.37 0.19
Non-Malays 1.00
Category duration 0.19
≥ 7 days 2.73 0.91 8.20 0.07
4–6 days 2.17 0.81 5.81 0.12
1–3 days 1.00
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papaya leaf extract. More number of studies should be
conducted in the future to identify the active compound
in crab soup, which has an antiviral activity against DF.
Additional file
Additional file 1: Questionnaire. (DOC 44 kb)
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